P1119: THE ORAL PI3KΔ INHIBITOR LINPERLISIB FOR THE TREATMENT OF RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA: A SINGLE-ARM MULTICENTER PHASE 2 CLINICAL TRIAL

Bibliographic Details
Main Authors:	T. wang, X. sun, L. qiu, H. su, J. cao, Z. li, Y. song, L. zhang, S. yi, J. zhou, H. wu, W. zhang, J. li, K. zhou, H. zhou, Y. yang, H. cen, Z. cai, Z. zhang, W. fu, J. jin, F. li, W. wu, X. gu, W. zhu, L. liu
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000847344.35314.45

Internet